Effects_NNS
of_IN
prostaglandin_NN
E2_NN
on_IN
Th0-type_JJ
human_JJ
T_NN
cell_NN
clones_NNS
:_:
modulation_NN
of_IN
functions_NNS
of_IN
nuclear_JJ
proteins_NNS
involved_VBN
in_IN
cytokine_NN
production_NN
._.

The_DT
effects_NNS
of_IN
prostaglandin_NN
E2_NN
-LRB-_-LRB-
PGE2_NN
-RRB-_-RRB-
on_IN
cytokine_NN
production_NN
and_CC
proliferation_NN
of_IN
the_DT
CD4_NN
+_CC
human_JJ
helper_NN
T_NN
cell_NN
clone_NN
SP-B21_NN
were_VBD
investigated_VBN
._.

In_IN
cells_NNS
stimulated_VBN
with_IN
anti-CD3_JJ
mAb_NN
,_,
PGE2_NN
inhibited_VBD
cell_NN
proliferation_NN
and_CC
the_DT
production_NN
of_IN
all_PDT
the_DT
cytokines_NNS
examined_VBN
._.

Addition_NN
of_IN
rIL-2_NN
fully_RB
restored_VBD
the_DT
proliferative_JJ
response_NN
and_CC
partially_RB
restored_VBD
the_DT
production_NN
of_IN
IL-4_NN
and_CC
IL-5_NN
,_,
but_CC
not_RB
that_DT
of_IN
other_JJ
cytokines_NNS
._.

In_IN
contrast_NN
,_,
in_IN
cells_NNS
stimulated_VBN
with_IN
phorbol_NN
myristate_NN
acetate_NN
-LRB-_-LRB-
PMA_NN
-RRB-_-RRB-
\/_JJ
A23187_NN
,_,
PGE2_NN
enhanced_VBD
the_DT
production_NN
of_IN
IL-4_NN
and_CC
IL-5_NN
,_,
and_CC
only_RB
partially_RB
inhibited_VBD
the_DT
production_NN
of_IN
other_JJ
cytokines_NNS
._.

Therefore_RB
,_,
the_DT
effects_NNS
of_IN
PGE2_NN
vary_VBP
depending_VBG
on_IN
the_DT
mode_NN
of_IN
T_NN
cell_NN
activation_NN
,_,
and_CC
the_DT
IL-4_NN
and_CC
IL-5_NN
are_VBP
regulated_VBN
differently_RB
from_IN
other_JJ
cytokines_NNS
._.

In_IN
a_DT
mobility_NN
shift_NN
assay_NN
,_,
only_RB
the_DT
NF-kappa_NN
B_NN
-LRB-_-LRB-
p50\/p50_NN
-RRB-_-RRB-
homodimer_NN
was_VBD
observed_VBN
in_IN
a_DT
complex_NN
formed_VBN
with_IN
the_DT
kappa_NN
B_NN
sequence_NN
in_IN
unstimulated_JJ
SP-B21_NN
cells_NNS
._.

When_WRB
cells_NNS
were_VBD
stimulated_VBN
with_IN
anti-CD3_JJ
mAb_NN
or_CC
PMA\/A23187_NN
,_,
a_DT
complex_JJ
formation_NN
of_IN
NF-kappa_NN
B_NN
-LRB-_-LRB-
p50\/p65_NN
-RRB-_-RRB-
heterodimer_NN
with_IN
the_DT
kappa_NN
B_NN
sequence_NN
was_VBD
induced_VBN
._.

Interestingly_RB
,_,
PGE2_NN
or_CC
di-butyryl_NN
-LRB-_-LRB-
Bt2_NN
-RRB-_-RRB-
cAMP_NN
abolished_VBD
the_DT
binding_NN
of_IN
NF-kappa_NN
B_NN
-LRB-_-LRB-
p50\/p65_NN
-RRB-_-RRB-
heterodimer_NN
to_TO
the_DT
kappa_NN
B_NN
sequence_NN
in_IN
cells_NNS
stimulated_VBN
with_IN
anti-CD3_JJ
mAb_NN
but_CC
not_RB
with_IN
PMA\/A23187_NN
._.

Our_PRP$
results_NNS
suggest_VBP
that_IN
the_DT
target_NN
of_IN
PGE2_NN
action_NN
is_VBZ
a_DT
component_NN
in_IN
the_DT
signal_NN
transduction_NN
pathway_NN
leading_VBG
to_TO
the_DT
activation_NN
of_IN
protein_NN
kinase_NN
C_NN
._.

However_RB
,_,
the_DT
inhibition_NN
of_IN
the_DT
T_NN
cell_NN
activation_NN
signals_NNS
by_IN
PGE2_NN
is_VBZ
selective_JJ
._.

PGE2_NN
enhanced_VBD
the_DT
complex_JJ
formation_NN
with_IN
NF-AT_NN
,_,
AP-1_NN
and_CC
CLE0_NN
sequences_NNS
when_WRB
the_DT
cells_NNS
were_VBD
activated_VBN
by_IN
either_CC
anti-CD3_JJ
mAb_NN
or_CC
PMA\/A23187_NN
stimulation_NN
._.

It_PRP
seems_VBZ
therefore_RB
that_IN
PGE2_NN
,_,
by_IN
elevating_NN
cAMP_NN
levels_NNS
,_,
interferes_VBZ
with_IN
the_DT
activation_NN
pathway_NN
for_IN
NF-kappa_NN
B_NN
but_CC
not_RB
for_IN
NF-AT_NN
,_,
AP-1_NN
or_CC
CLE0_NN
binding_NN
protein_NN
._.

